Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

G0 Phase

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on G0 Phase:

Pubmed Logo
Expression of p-Akt and COX-2 in Gastric Adenocarcinomas and Adenovirus Mediated Akt1 and COX-2 ShRNA Suppresses SGC-7901 Gastric Adenocarcinoma and U251 Glioma Cell Growth In Vitro and In Vivo.
Cyclooxygenase-2 (COX-2) and Protein kinase B (PKB/Akt) play a crucial...
21st November, 2009
Gastroenterology, Tianjin Medical University General Hospital, 154 An-Shan Technol Cancer Res Treat. 2009 Dec;8(6):467-478.
Inhibition of proliferation of a hepatoma cell line by fucoxanthin in relation to cell cycle arrest and enhanced gap junctional intercellular communication.
Fucoxanthin is one of the most abundant carotenoids found in Undaria...
17th November, 2009
Department of Food Science, National Chung-Hsing University, 250 Kuo-Kuang Chem Biol Interact. 2009 Dec 10;182(2-3):165-72. Epub 2009 Sep 6.
DOI Direct Link
Quantifying thymic export: combining models of naive T cell proliferation and TCR excision circle dynamics gives an explicit measure of thymic output.
Understanding T cell homeostasis requires knowledge of the export rate of...
17th November, 2009
Immunobiology Unit, Institute of Child Health, University College London, J Immunol. 2009 Oct 1;183(7):4329-36. Epub 2009 Sep 4.
DOI Direct Link
Cell cycle progression following naive T cell activation is independent of Jak3/common gamma-chain cytokine signals.
T cell proliferation following activation is an essential aspect of the...
17th November, 2009
Department of Pathology, University of Massachusetts Medical School, J Immunol. 2009 Oct 1;183(7):4493-501. Epub 2009 Sep 4.
DOI Direct Link
Efficient and stable transduction of resting B lymphocytes and primary chronic lymphocyte leukemia cells using measles virus gp displaying lentiviral vectors.
Up to now, no lentiviral vector (LV) tool existed to govern efficient and...
29th October, 2009
Inserm U758, Human Virology Department, Universite de Lyon, Ecole Normale Blood. 2009 Oct 8;114(15):3173-80. Epub 2009 Aug 10.
DOI Direct Link

View more research publications.

Press Releases About G0 Phase:

BioPortfolio Logo
Pharmasset Reports Fiscal Year End 2009 Financial Results 25th November, 2009 Pharmasset, Inc.
PRINCETON, N.J., Nov. 25 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS), a clinical stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to
Onyx Pharmaceuticals Announces December 2009 Investor Events 25th November, 2009 Onyx Pharmaceuticals, Inc.
EMERYVILLE, Calif., Nov. 25 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that the company will host two investor events in December: ASH Briefing December 7,
The Lupus Foundation of America Hosts Special Webinar to Discuss BENLYSTA(TM) Results 25th November, 2009 Lupus Foundation of America
WHAT: The Lupus Foundation of America (LFA) invites those living with lupus to a special Webinar with LFA's Medical Director, Dr. Joan Merrill. Human Genome Sciences (HGSI) and GlaxoSmithKline
Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 25th November, 2009 Ardea Biosciences, Inc.
SAN DIEGO, Nov. 25 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA) announced today that Barry D. Quart, Pharm.D., president and chief executive officer, will present at the Piper
Reportlinker Adds Wound Care Products - A World Market Analysis 25th November, 2009 Reportlinker
NEW YORK, Nov. 25 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Wound Care Products - A World Market Analysis http://www.reportlinker.com

BioNews Results for G0 Phase:

RSS Logo
BioPortfolio Logo
Stem Cell Therapeutics (SSS.V) Announces Positive Review by Data Safety and Monitoring Board for the Phase IIb
BioSpace:  Nov 21 2009 12:39AM Matching: phase
AFFiRiS AG: Alzheimer's Vaccine Candidate AD02 moves into Clinical Phase II Testing
Bionity.com:  Nov 21 2009 5:25AM Matching: phase
Stem Cell Therapeutics Corp. Announces Positive Review by Data Safety and Monitoring Board for the Phase IIb S
Canadian Business Magazine:  Nov 20 2009 1:48PM Matching: phase
Stem Cell Therapeutics Corp. Announces Positive Review by Data Safety and Monitoring Board for the Phase IIb S
Canadian Business Magazine:  Nov 20 2009 1:48PM Matching: phase
AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate
KOTA Territory News:  Nov 20 2009 10:37AM Matching: phase
Promote your company here: BioNewsCast - Press Release Distribution

View more news.

G0 Phase Patents:

USPTO Logo
US Patent No.Title
7064245 Process for reconstructing a non-human mammalian embryo by nuclear transfer using a heat treated donor nucleus and preparaing a non-human mammal
7326825 Methods of ungulate nuclear transfer
7329796 Serial nuclear transfer of ungulate embryos
7332648 Unactivated oocytes in nuclear transfer to produce cultured inner cell mass cells and ungulates
7338774 Method for determining activity of cell cycle regulatory factor and method for diagnosing cancer using the same

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for G0 Phase scientists - we have details of around 152 individuals working on G0 Phase .


This page has been viewed 589 times
Recent Search Terms used to find this page: g0 phase | what is g0 phase | cancer and g0 phase | g0 Phase | g0 phase | g0 phase | g0 phase cancer | what is the G0 stage | The G0 phase dealing with cancer | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for G0 Phase across BioPortfolio, or for G0 Phase Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.